JAYANTHI ALAGARSAMY

Allopathic & Osteopathic Physicians|Internal Medicine SOLON, OH NPI 1710976089

General Payments — all program years on this page

$2,788.51

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 120
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $680.81 across 12 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $680.8112

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $413.186
Vanda Pharmaceuticals Inc. $190.482
Lilly USA, LLC $35.532
Novo Nordisk AS $23.241
Exact Sciences Corporation $18.381

By program year

Program yearAmountRecords
2018 $290.2017
2019 $358.5415
2020 $429.7129
2021 $542.9522
2022 $470.6324
2023 $15.671
2024 $680.8112

Records — PY2024 (12)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1097353924 Novo Nordisk Inc $23.24 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104216375 AstraZeneca Pharmaceuticals LP $18.36 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104471042 AstraZeneca Pharmaceuticals LP $125.00 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104601210 AstraZeneca Pharmaceuticals LP $124.99 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105565448 AstraZeneca Pharmaceuticals LP $5.74 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105762150 AstraZeneca Pharmaceuticals LP $125.00 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105883753 AstraZeneca Pharmaceuticals LP $14.09 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114572478 Exact Sciences Corporation $18.38 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133894383 Vanda Pharmaceuticals Inc. $124.99 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133894385 Vanda Pharmaceuticals Inc. $65.49 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135033442 Lilly USA, LLC $18.43 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135035384 Lilly USA, LLC $17.10 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.